Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery

Nursing and Health Professions

• Lidocaine 100%
• Heart Surgery 41%
• Deterioration 33%
• Placebo 33%
• Patient 16%
• Diabetes Mellitus 16%
• Analysis 16%
• Low Drug Dose 16%
• Postoperative Cognitive Dysfunction 16%
• Incidence 8%
• Procedures 8%
• Electric Potential 8%
• Dose 8%
• Quality of Life 8%
• Infusion 8%
• Cognitive Defect 8%
• Drug Megadose 8%
• Group Therapy 8%
• Continuous Infusion 8%
• Placebo-Controlled Study 8%
• Cardiopulmonary Bypass 8%
• Neuroprotection 8%

Neuroscience

• Lidocaine 100%
• Placebo 41%
• Predictor 16%
• Postoperative Cognitive Dysfunction 16%
• Cognition 8%
• Diabetes 8%
• Neuroprotection 8%
• Cognitive Disorders 8%
• Cognitive Function 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Lidocaine 100%
• Deterioration 33%
• Diabetes Mellitus 16%
• Postoperative Cognitive Dysfunction 16%
• Incidence 8%
• Cognitive Defect 8%
• Placebo-Controlled Study 8%
• Controlled Clinical Trial 8%